返回 Agenda
Session 4: UK MHRA and BREXIT – Next Steps. Concrete Clinical Trials Disclosure Aspects
Session Chair(s)
Scott Feiner
Senior Manager, Trial Disclosure
AbbVie, United States
UK MHRA and BREXIT – Next Steps. Concrete Clinical Trials Disclosure Aspects
Speaker(s)
Overview of Latest MHRA Guidance for Clinical Trials Post-Brexit
Scott Feiner
AbbVie, United States
Senior Manager, Trial Disclosure
Brexit and Clinical Trial Disclosure in the UK
Amanda Hunn, MA
AJ Hunn Associates, United Kingdom
Self-employed Advisor/Formerly Head of Policy and Public Affairs At the HRA